Statistics for Final 192-week efficacy and safety results of the ADVANCE Trial, comparing 3 first-line antiretroviral regimens
Total visits
| views | |
|---|---|
| Final 192-week efficacy and safety results of the ADVANCE Trial, comparing 3 first-line antiretroviral regimens | 18 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 10 |
| September 2024 | 1 |
| October 2024 | 1 |
| November 2024 | 0 |
| December 2024 | 6 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Sokhela_Final_2024.pdf | 22 |
Top country views
| views | |
|---|---|
| South Africa | 11 |
| United States | 4 |
| Brazil | 1 |
| Japan | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Johannesburg | 10 |
| Durham | 4 |
| Chiyoda-ku | 1 |
| Groblersdal | 1 |
| Novosibirsk | 1 |
| São Paulo | 1 |